Lukas Scheibler - Net Worth and Insider Trading
Lukas Scheibler Net Worth
The estimated net worth of Lukas Scheibler is at least $2 Million dollars as of 2024-12-27. Lukas Scheibler is the Chief Research Officer of Apellis Pharmaceuticals Inc and owns about 68,299 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $2 Million. Lukas Scheibler is also the EVP of Research & Development of Macy's Inc and owns about 11,108 shares of Macy's Inc (M) stock worth over $201,055. Details can be seen in Lukas Scheibler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lukas Scheibler has not made any transactions after 2023-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lukas Scheibler
Lukas Scheibler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lukas Scheibler owns 2 companies in total, including Apellis Pharmaceuticals Inc (APLS) , and Acucela Inc (AUCL) .
Click here to see the complete history of Lukas Scheibler’s form 4 insider trades.
Insider Ownership Summary of Lukas Scheibler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2023-12-01 | See Remarks |
| AUCL | Acucela Inc | 2017-07-17 | EVP of Research & Development |
Lukas Scheibler Latest Holdings Summary
Lukas Scheibler currently owns a total of 2 stocks. Among these stocks, Lukas Scheibler owns 68,299 shares of Apellis Pharmaceuticals Inc (APLS) as of December 1, 2023, with a value of $2 Million and a weighting of 91.8%. Lukas Scheibler also owns 11,108 shares of Macy's Inc (M) as of July 17, 2017, with a value of $201,055 and a weighting of 8.2%.
Latest Holdings of Lukas Scheibler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2023-12-01 | 68,299 | 32.96 | 2,250,794 |
| M | Macy's Inc | 2017-07-17 | 11,108 | 18.10 | 201,055 |
Holding Weightings of Lukas Scheibler
Lukas Scheibler Form 4 Trading Tracker
According to the SEC Form 4 filings, Lukas Scheibler has made a total of 9 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 10,000 shares on December 1, 2023, which brought Lukas Scheibler around $600,000.
According to the SEC Form 4 filings, Lukas Scheibler has made a total of 0 transactions in Macy's Inc (M) over the past 5 years. The most-recent trade in Macy's Inc is the sale of 1,250 shares on July 17, 2017, which brought Lukas Scheibler around $8,125.
Insider Trading History of Lukas Scheibler
- 1
Lukas Scheibler Trading Performance
GuruFocus tracks the stock performance after each of Lukas Scheibler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lukas Scheibler is -10.08%. GuruFocus also compares Lukas Scheibler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lukas Scheibler within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lukas Scheibler's insider trading performs compared to the benchmark.
Performance of Lukas Scheibler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.51 | | | | | |
| Relative Return to S&P 500(%) | 6.52 | | | | | |
Lukas Scheibler Ownership Network
Lukas Scheibler Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Lukas Scheibler is the See Remarks of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include General Counsel David O. Watson , See Remarks James George Chopas , and Chief Operating Officer Pascal Deschatelets .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Lukas Scheibler made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 284,688 shares made by Pascal Deschatelets , a net sale of 433,087 shares made by Cedric Francois , and a net sale of 33,060 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 5,000 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 1,149,172 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,149,172 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Lukas Scheibler Mailing Address
Above is the net worth, insider trading, and ownership report for Lukas Scheibler. You might contact Lukas Scheibler via mailing address: C/o Apellis Pharmaceuticals, Inc., 6400 Westwind Way, Suite A, Crestwood Ky 40014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
